Guide price only. Final cost is confirmed after assessment.
At London Cartilage Clinic, we are at the forefront of meniscus regeneration, offering state-of-the-art treatments for meniscus injuries - one of the most common injuries that result in functional impairment in the knee.
Reviewed byProf Paul Lee MBBch, FRCS (Tr & Orth), PhDLast reviewed 1 May 2026
The meniscus helps absorb impact and stabilise the knee. When it is damaged, everyday movement, exercise, and sport can become painful or unreliable.
Our focus is to preserve meniscal tissue where possible and improve the biological environment for healing, helping you stay active for longer.
Common symptoms include pain, swelling, clicking, and loss of confidence in the knee. We combine clinical assessment with MRI to define tear pattern, tissue quality, and joint alignment before recommending treatment.
Your pathway is personalised and may combine rehabilitation, targeted injection therapy, or surgery depending on symptoms, goals, and scan findings.
With specialist meniscus expertise, we focus on durable symptom relief and safer return to daily activity and sport.
Meniscus regeneration involves using regenerative medicine techniques to heal and reconstruct damaged meniscal tissue.
Treatments include MFAT, BMAC, and PRP therapy, among others.
Diagnosis typically combines specialist clinical examination with MRI. X-rays can help assess bone and joint alignment but do not directly diagnose meniscus tears; arthroscopy may be used in selected cases.
Yes, including medications, physiotherapy, and lifestyle changes.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
Hip cartilage lacks blood supply; once damaged, stress concentrates at the defect edge, widening the lesion in a self-reinforcing cycle that leads inevitably to bone-on-bone contact and osteoarthritis unless treated.
ChondroFiller is the same collagen scaffold in both the UK and Germany, but the UK delivers it as a 30–45-minute ultrasound-guided outpatient injection with same-day discharge, whilst Germany uses arthroscopic surgery under anaesthesia requiring post-operative immobilisation and months of physiotherapy.
ChondroFiller is an acellular collagen scaffold that recruits the patient's own progenitor cells to drive cartilage repair; suitability depends on three factors: damage grade, joint mechanics, and systemic health.
